Medical costs of glaucoma and ocular hypertension in Italian referral centres: A prospective study

Ophthalmologica

Volumn 221, Issue 5, 2007, Pages 340-347

  Koleva, Daniela ^a   Motterlini, Nicola ^a   Schiavone, Mauro ^b   Garattini, Livio ^a,c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^c CESAV   (Italy)

Author keywords

Glaucoma, costs; Glaucoma, Italy; Ocular hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN DERIVATIVE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG COST; FEMALE; GLAUCOMA; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; VISUAL ACUITY;

AGE FACTORS; AGED; DRUG COSTS; FEMALE; GLAUCOMA; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; ITALY; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; SEVERITY OF ILLNESS INDEX; SPECIALTIES, MEDICAL; VISUAL ACUITY;

EID: 34548301810     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104765     Document Type: Article

References (23)

1. Tuulonen A, Airksinen PJ, Erola E, Forsman E, Friberg K, Kaila M, Klemetti A, Mäkelä M, Oskala P, Puska P, Suoranta L, Teir H, Uusitalo H, Vainio-Jylhä E, Vuori ML: The Finnish evidence-based guideline for open-angle glaucoma. Acta Ophthalmol Scand 2003;81:3-18.
2. Distelhorst JS, Hughes GM: Open-angle glaucoma. Am Fam Physician 2003;67:1937-1944.
3. Yanoff M, Duker JS: Ophthalmology. London, Mosby International Limited, 1998.
4. Bonomi L, Marchini G, Maraffa M, Bernardi P, De Franco I, Perfetti S, Varotto A: Epidemiology of angle-closure glaucoma: prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarket Glaucoma Study. Ophthalmology 2000;107:998-1003.
5. European Glaucoma Society (EGS): Terminology and Guidelines for Glaucoma. Savona, Dogma, 2003.
6. Rouland JF, Peigne G, Sellem E, Renard JP, Williamson W, Filippi JM, Cohn H, Hamard P, Abellan P, Chagnon A, Malet F, Haye I: An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients. J Fr Ophthalmol 2001;24:233-243.
7. Oostenbrink JB, Rutten-van Molken MPMH, Sluyter-Updenoordt TS: Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands. J Glaucoma 2001;10:184-191.
8. Kobelt-Nguyen G, Gerdtham U, Alm A: Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States. J Glaucoma 1998;7:95-104.
9. Denis P, Lafuma A, Berdeaux G: Medical predictive factors of glaucoma treatment costs. J Glaucoma 2004;13:283-290.
10. Traverso CE, Walt JG, Kelly SP, Hommer AH, Bron AM, Denis P, Nordmann JP, Renard JP, Bayer A, Grehn F, Pfeiffer N, Cedrone C, Gandolfi S, Orzalesi N, Nucci C, Rossetti L, Azuara-Blanco A, Bagnis A, Hitchings R, Salmon JF, Bricola G, Buchholz PM, Kotak SV, Katz LM, Siegartel LR, Doyle JJ: Direct cost of glaucoma and severity of the disease: a multinational long-term study of resource utilization in Europe. Br J Ophthalmol 2005;89:1245-1249.
11. Iskedjian M, Walker J, Vicente C, Trope G, Buys Y, Einarson TR, Covert D: Cost of glaucoma in Canada: analyses based on visual field and physician's assessment. J Glaucoma 2003;12:456-462.
12. France G, Taroni F: The evolution of health-policy making in Italy. J Health Polit Policy Law 2005;30:169-187.
13. Taroni F: DRG/ROD e nuovo sistema di finanziamento degli ospedali. Rome, Il Pensiero Scientifico Editore, 1996.
14. Koleva D, Motterlini N, Schiavone M, Garattini L: I costi del glaucoma in Italia: l'analisi retrospettiva dello studio GLAUCO. EPF 2004;3:34-41.
15. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1997.
16. Garattini L, Grilli R, Scopelliti D, Mantovani L: A proposal for Italian guidelines in pharmacoeconomics. Pharmacoeconomics 1995;7:1-6.
17. Koçac I, Zulauf M, Bergamin O: Evaluation of the Brusini glaucoma staging system for typing and staging of perimetric results. Ophthalmologica 1998;212:221-227.
18. Motterlini N, Cornago D, Garattini L: I costi di struttura dei reparti di oftalmologia in Italia. Farmacoeconomia News 2006;2:3-7.
19. Garattini L, Giuliani G, Pagano E: A model for calculating costs of hospital wards: an Italian experience. J Manag Med 1999;13:71-82.
20. Carpenter J, Bithell J: Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 2000;19:1141-1164.
21. De Natale R, Draghi E, Dorigo MT: How prostaglandins have changed the medical approach to glaucoma and its costs: an observational study of 2228 patients treated with glaucoma medications. Acta Ophthalmol Scand 2004;82:393-396.
22. Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A: Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess 2004;8:1-192.
23. Boulenger S, Nixon J, Drummond M, Ulmann P, Rice S, de Pouvourville G: Can economic evaluations be made more transferable? Eur J Health Econ 2005;6:334-346.